ACADIA PHARMACEUTICALS INC — Form 4
Filed August 7, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 49/100
What the filing says
EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. (ACAD) sold 40K shares (~$587K) on the open market (40% of holdings). Large sale — ~40% of holdings.
Why this rating
Large sale — ~40% of holdings.
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.